Press releases

On November 8, 2018, 16 Australian researchers visited Fraunhofer ITEM as part of the InnoTour 2018. In addition to lectures on the “Integration of Human Tissue for Research and Development”, the guests were offered guided tours through the clinical research center CRC Hannover, which gave the Australian visitors an insight into the state of the art of in-vitro toxicology and ex-vivo methods.

Hip and dental implant operations are routine. But not entirely risk-free. They may result in infection that is difficult to control with oral or intravenous antibiotics. In such cases, the implant will probably need to be replaced. Fraunhofer researchers can now apply a precisely matched drug directly to the replacement implant while significantly increasing the effectiveness of the antibiotic via a synergism with silver ions. Their research will be on display at the MEDICA and COMPAMED trade fairs in Düsseldorf from November 12 to 15, 2018 (Hall 8a, Booth P13).

Patient safety is top priority in medicine and biomedical engineering. Aiming to increase patient safety, the EU introduced the European Medical Device Regulation (MDR) in 2017. Representatives of the medtech sector are expecting massive negative consequences from the regulation and are suggesting specific measures for a revision of the MDR.

The last event within the Fraunhofer initiative InnoHealth Australia will take place in Germany from November 5 to 9 – InnoTour 2018. Executed by the Fraunhofer-Gesellschaft, this tour will bring 16 Australian researchers and innovators to different institutions and SMEs of the German healthcare sector.

Together with three other Fraunhofer Institutes, Fraunhofer ITEM hosted the Science Campus from September 24 to 26, 2018, aimed at attracting female students and graduates in the STEM subjects to work in applied research.

Researcher Prof. Christoph Klein, Fraunhofer ITEM Division Director of Personalized Tumor Therapy and Senior Professor of Experimental Medicine and Therapy Research at the University of Regensburg (Germany) has been given the international “I.J. ‘Josh‘ Fidler Innovation in Metastasis Research Award”. Prof. Klein received this award for his innovative contributions to metastasis research. The award ceremony took place in Princeton, USA, on August 3, 2018, during the 17th Congress of the Metastasis Research Society.

In the development of new medications and medical engineering, there is a gap between the discovery of new potential active ingredients and products and their further development into medicinal products and medical devices by the industry. The Helmholtz Association and the Fraunhofer-Gesellschaft, together with the Deutsche Hochschulmedizin, have now jointly brought the Proof-of-Concept initiative into being. It promotes the translation of innovative, promising research projects.

A pioneering collaboration of three partners – Fraunhofer ITEM, the Hannover Medical School (MHH), and Griffith University’s Institute for Glycomics (IfG) in Gold Coast, Australia – was officially launched on January 18, 2018. The aim of the collaborative project iCAIR is to develop new anti-infective drugs.

(Hannover, Germany) Bacteria worldwide keep developing new resistances to antibiotics. Alternative therapies are urgently needed to meet this challenge. To this end, the Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, Leibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures, Charité – Universitätsmedizin Berlin, and Charité Research Organisation have teamed up and initiated the project “Phage4Cure”. The goal is to establish bacteriophages as an approved drug for treating bacterial infections. The German Federal Ministry of Education and Research is funding this project with almost four million euros over a period of three years.

The Hannover Science Initiative is celebrating its anniversary: for 10 years now, the 15 partners in the Initiative, among them Hannover’s nine universities and higher-education institutes, the Student Administration, science-affiliated institutions such as the Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, hannoverimpuls GmbH, and the State Capital of Hannover, have been successfully cooperating.